BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11711700)

  • 1. Diagnostic dilemmas in parathyroid scintigraphy.
    Krausz Y; Shiloni E; Bocher M; Agranovicz S; Manos B; Chisin R
    Clin Nucl Med; 2001 Dec; 26(12):997-1001. PubMed ID: 11711700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
    Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
    Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
    Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal pinhole techniques for preoperative localization with Tc-99m MIBI for primary hyperparathyroidism.
    Ho Shon IA; Roach PJ; Bernard EJ; Delbridge LW
    Clin Nucl Med; 2001 Dec; 26(12):1002-9. PubMed ID: 11711701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
    Rubello D; Saladini G; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
    Powell DK; Nwoke F; Goldfarb RC; Ongseng F
    Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease.
    Krausz Y; Lebensart PD; Klein M; Weininger J; Blachar A; Chisin R; Shiloni E
    World J Surg; 2000 Dec; 24(12):1573-8. PubMed ID: 11193726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
    Casara D; Rubello D; Pelizzo MR; Shapiro B
    Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism.
    Berczi C; Mezõsi E; Galuska L; Varga J; Bajnok L; Lukács G; Balázs G
    Eur Radiol; 2002 Mar; 12(3):605-9. PubMed ID: 11870476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of 99mTc-methoxy-isobutyl-isonitrile scintigraphy for preoperative localization of adenoma in primary hyperparathyroidism].
    Yamaguchi S; Kobayashi Y; Tsujikawa K; Noma M; Mori N; Hara T; Takao T; Takada S; Sugao H; Yoshida S
    Hinyokika Kiyo; 2001 Sep; 47(9):619-23. PubMed ID: 11692597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
    Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
    Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.
    Kebapci M; Entok E; Kebapci N; Adapinar B
    J Endocrinol Invest; 2004 Jan; 27(1):24-30. PubMed ID: 15053239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radionuclide imaging of the parathyroid glands.
    Palestro CJ; Tomas MB; Tronco GG
    Semin Nucl Med; 2005 Oct; 35(4):266-76. PubMed ID: 16150247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
    Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
    Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
    Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
    Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R; Boucher Y; Potvin C; Lambert R
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD; Dupont JO; Bybel B; Riese KT
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism.
    Bergenfelz A; Tennvall J; Valdermarsson S; Lindblom P; Tibblin S
    Surgery; 1997 Jun; 121(6):601-5. PubMed ID: 9186458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.